Clinical trial
Biological Analysis of a Series of Thymoma and Thymic Carcinoma: Genetic Aberrations and Potential Therapy Targets.
NCT00965627 is registered in ClinicalTrials.gov with Istituto Clinico Humanitas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biological Analysis of a Series of Thymoma and Thymic Carcinoma: Genetic Aberrations and Potential Therapy Targets.
- Lead sponsor
- Istituto Clinico Humanitas
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- August 31, 2009
- Enrollment
- 134 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.